Geographical variation in the progression of type 2 diabetes in Peru: The CRONICAS Cohort Study

Antonio Bernabé-Ortiz, Rodrigo M Carrillo-Larco, Robert H Gilman, Catherine H Miele, William Checkley, Jonathan C Wells, Liam Smeeth, J Jaime Miranda, CRONICAS Cohort Study Group, Antonio Bernabé-Ortiz, Rodrigo M Carrillo-Larco, Robert H Gilman, Catherine H Miele, William Checkley, Jonathan C Wells, Liam Smeeth, J Jaime Miranda, CRONICAS Cohort Study Group

Abstract

Background: The study aims were to estimate the incidence and risk factors for T2D in four settings with different degree of urbanization and altitude in Peru.

Methods: Prospective cohort study conducted in urban, semi-urban, and rural areas in Peru. An age- and sex-stratified random sample of participants was taken from the most updated census. T2D was defined as fasting blood glucose ⩾7.0mmol/L or taking anti-diabetes medication. Exposures were divided into two groups: geographical variables (urbanization and altitude), and modifiable risk factors. Incidence, relative risks (RR), 95% confidence intervals (95%CI), and population attributable fractions (PAF) were estimated.

Results: Data from 3135 participants, 48.8% males, mean age 55.6years, was analyzed. Overall baseline prevalence of T2D was 7.1% (95%CI 6.2-8.0%). At follow-up, including 6207 person-years of follow-up, a total of 121 new T2D cases were accrued, equating to an incidence of 1.95 (95%CI 1.63-2.33) per 100 person-years. There was no urban to rural gradient in the T2D incidence; however, compared to sea level sites, participants living in high altitude had a higher incidence of diabetes (RR=1.58; 95%CI 1.01-2.48). Obesity had the highest attributable risk for developing T2D, although results varied by setting, ranging from 14% to 80% depending on urbanization and altitude.

Conclusions: Our results suggest that the incidence of T2D was greater in high altitude sites. New cases of diabetes were largely attributed to obesity, but with substantial variation in the contribution of obesity depending on the environment. These findings can inform appropriate context-specific strategies to reduce the incidence of diabetes.

Keywords: Altitude; Incidence; Obesity; Risk factors; Type 2 diabetes.

Conflict of interest statement

The authors have nothing to disclose.

Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Figures

Fig. 1
Fig. 1
Map of Peru indicating the CRONICAS Cohort Study’s sites.
Fig. 2
Fig. 2
Baseline enrollment and follow-up of the CRONICAS Cohort Study.

References

    1. World Health Organization . WHO; Geneva, Switzerland: 2014. Global status report on noncommunicable diseases 2014.
    1. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
    1. Danaei G., Finucane M.M., Lu Y., Singh G.M., Cowan M.J., Paciorek C.J. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378(9785):31–40.
    1. Ebrahim S., Pearce N., Smeeth L., Casas J.P., Jaffar S., Piot P. Tackling non-communicable diseases in low- and middle-income countries: is the evidence from high-income countries all we need? PLoS Med. 2013;10(1):e1001377.
    1. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Meigs J.B. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. Diabetes. 2004;53(7):1782–1789.
    1. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–2223.
    1. Huicho L., Trelles M., Gonzales F., Mendoza W., Miranda J. Mortality profiles in a country facing epidemiological transition: an analysis of registered data. BMC Public Health. 2009;9:47.
    1. Goldstein J., Jacoby E., del Aguila R., Lopez A. Poverty is a predictor of non-communicable disease among adults in Peruvian cities. Prev Med. 2005;41(3–4):800–806.
    1. Eckert S., Kohler S. Urbanization and health in developing countries: a systematic review. World Health Popul. 2014;15(1):7–20.
    1. Bigham A.W., Lee F.S. Human high-altitude adaptation: forward genetics meets the HIF pathway. Genes Dev. 2014;28(20):2189–2204.
    1. Santos J.L., Perez-Bravo F., Carrasco E., Calvillan M., Albala C. Low prevalence of type 2 diabetes despite a high average body mass index in the Aymara natives from Chile. Nutrition. 2001;17(4):305–309.
    1. Xu S., Jiayong Z., Li B., Zhu H., Chang H., Shi W. Prevalence and clustering of cardiovascular disease risk factors among Tibetan Adults in China: a population-based study. PLoS ONE. 2015;10(6):e0129966.
    1. Niemeyer S., Zamudio S., Moore L.G. The people. In: Hornbein T.F., Schoene R.B., editors. High altitude: an exploration of human adaptation. Marcel Dekker Inc; New York, NY: 2001. pp. 43–100.
    1. Christine P.J., Auchincloss A.H., Bertoni A.G., Carnethon M.R., Sanchez B.N., Moore K. Longitudinal associations between neighborhood physical and social environments and incident type 2 diabetes mellitus: the multi-ethnic study of atherosclerosis (MESA) JAMA Intern Med. 2015;175(8):1311–1320.
    1. Miranda J.J., Bernabe-Ortiz A., Smeeth L., Gilman R.H., Checkley W., Group CCS Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open. 2012;2(1):e000610.
    1. The National Institute of Statistics and Informatics. Peru. Available in: <>.
    1. American Diabetes A Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl. 1):S81–S90.
    1. Daeppen J.B., Yersin B., Landry U., Pecoud A., Decrey H. Reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) imbedded within a general health risk screening questionnaire: results of a survey in 332 primary care patients. Alcohol Clin Exp Res. 2000;24(5):659–665.
    1. Hu F.B., Li T.Y., Colditz G.A., Willett W.C., Manson J.E. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA. 2003;289(14):1785–1791.
    1. Lim S.S., Vos T., Flaxman A.D., Danaei G., Shibuya K., Adair-Rohani H. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260.
    1. World Health Organization and Food and Agriculture of the United Nations. Fruit and vegetables for health. Report of a joint FAO/WHO workshop. Geneva, Switzerland: WHO; 2005.
    1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
    1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jr. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572.
    1. Yeh H.C., Punjabi N.M., Wang N.Y., Pankow J.S., Duncan B.B., Brancati F.L. Vital capacity as a predictor of incident type 2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005;28(6):1472–1479.
    1. Jaganath D., Miranda J.J., Gilman R.H., Wise R.A., Diette G.B., Miele C.H. Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res. 2015;16:40.
    1. Miele C.H., Schwartz A., Gilman R.H., Pham L., Wise R.A., Davila-Roman V.G. Increased cardiometabolic risk and worsening hypoxemia at high altitude. High Alt Med Biol. 2016;17(2):93–100.
    1. Mackenzie R., Maxwell N., Castle P., Elliott B., Brickley G., Watt P. Intermittent exercise with and without hypoxia improves insulin sensitivity in individuals with type 2 diabetes. J Clin Endocrinol Metab. 2012;97(4):E546–E555.
    1. Lee Y.S., Kim J.W., Osborne O., Oh da Y., Sasik R., Schenk S. Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell. 2014;157(6):1339–1352.
    1. Jun J.C., Shin M.K., Devera R., Yao Q., Mesarwi O., Bevans-Fonti S. Intermittent hypoxia-induced glucose intolerance is abolished by alpha-adrenergic blockade or adrenal medullectomy. Am J Physiol Endocrinol Metab. 2014;307(11):E1073–E1083.
    1. Barcelo A., Daroca M.C., Ribera R., Duarte E., Zapata A., Vohra M. Diabetes in Bolivia. Rev Panam Salud Publica. 2001;10(5):318–323.
    1. Carrasco E.P., Perez F.B., Angel B.B., Albala C.B., Santos J.L., Larenas G.Y. Prevalence of type 2 diabetes and obesity in two Chilean aboriginal populations living in urban zones. Rev Med Chil. 2004;132(10):1189–1197.
    1. Bermudez O.I., Tucker K.L. Trends in dietary patterns of Latin American populations. Cad Saude Publica. 2003;19(Suppl. 1):S87–S99.
    1. Ruiz-Linares A., Adhikari K., Acuna-Alonzo V., Quinto-Sanchez M., Jaramillo C., Arias W. Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7342 individuals. PLoS Genet. 2014;10(9):e1004572.
    1. Li Y., Ley S.H., Tobias D.K., Chiuve S.E., VanderWeele T.J., Rich-Edwards J.W. Birth weight and later life adherence to unhealthy lifestyles in predicting type 2 diabetes: prospective cohort study. BMJ. 2015;351:h3672.
    1. Branchtein L., Schmidt M.I., Matos M.C., Yamashita T., Pousada J.M., Duncan B.B., Brazilian Gestational Diabetes Study Group Short stature and gestational diabetes in Brazil. Diabetologia. 2000;43(7):848–851.
    1. Lawlor D.A., Ebrahim S., Davey Smith.G. The association between components of adult height and Type II diabetes and insulin resistance: British Women’s Heart and Health Study. Diabetologia. 2002;45(8):1097–1106.
    1. Gunnell D., Smith G.D., McConnachie A., Greenwood R., Upton M., Frankel S. Separating in-utero and postnatal influences on later disease. Lancet. 1999;354(9189):1526–1527.
    1. Tam C.H., Wang Y., Luan J., Lee H.M., Luk A.O., Tutino G.E. Non-linear relationship between birthweight and cardiometabolic risk factors in Chinese adolescents and adults. Diabet Med. 2015;32(2):220–225.
    1. Pomeroy E., Stock J.T., Stanojevic S., Miranda J.J., Cole T.J., Wells J.C. Trade-offs in relative limb length among Peruvian children: extending the thrifty phenotype hypothesis to limb proportions. PLoS ONE. 2012;7(12):e51795.
    1. Guh D.P., Zhang W., Bansback N., Amarsi Z., Birmingham C.L., Anis A.H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
    1. Vazquez G., Duval S., Jacobs D.R., Jr., Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29:115–128.
    1. Barquera S., Hernandez-Barrera L., Campos-Nonato I., Espinosa J., Flores M.J.A.B. Energy and nutrient consumption in adults: analysis of the Mexican National Health and Nutrition Survey 2006. Salud Publica Mex. 2009;51(Suppl. 4):S562–S573.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner